Recruiting × Interventional × Esophageal Neoplasms × Clear all REACH
Phase NA Recruiting
257 enrolled
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Phase 1 Recruiting
42 enrolled
The Vanguard Study: Testing a New Way to Screen for Cancer
Phase NA Recruiting
24,000 enrolled
MK-3475-06D
Phase 1/2 Recruiting
210 enrolled
MK-3475-06C
Phase 1/2 Recruiting
160 enrolled
FAPI-GO
Phase 3 Recruiting
200 enrolled
HEARTS Trial for Thoracic Cancers
Phase 2 Recruiting
60 enrolled
PEGASUS
Phase 2 Recruiting
30 enrolled
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Phase 4 Recruiting
22 enrolled
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Phase 2 Recruiting
40 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer
Phase 1/2 Recruiting
105 enrolled
MK-3475-06B
Phase 1/2 Recruiting
230 enrolled
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2 Recruiting
134 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 Recruiting
60 enrolled
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Phase NA Recruiting
600 enrolled
Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
22 enrolled
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 Recruiting
200 enrolled
Endeavor-1
Phase NA Recruiting
50 enrolled
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Phase 3 Recruiting
2,130 enrolled
DG-03
Phase 2 Recruiting
450 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
MAGECmultiDiCE
Phase NA Recruiting
2,200 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
Phase NA Recruiting
200 enrolled
MAGEC
Phase NA Recruiting
1,000 enrolled
EXCEED
Phase 1 Recruiting
490 enrolled
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Phase NA Recruiting
20 enrolled
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 Recruiting
452 enrolled
VISTA
Phase 1 Recruiting
45 enrolled
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 Recruiting
150 enrolled
OPTIMUS
Phase NA Recruiting
50 enrolled
POISE
Phase 3 Recruiting
20 enrolled
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 Recruiting
470 enrolled
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Phase 2 Recruiting
49 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Phase NA Recruiting
1,550 enrolled
SCR-ESCC-01
Phase 2 Recruiting
100 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Phase 3 Recruiting
2,000 enrolled
Neoadjuvant Treatment Modalities in Esophageal Cancer
Phase 3 Recruiting
2,000 enrolled
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Phase 1/2 Recruiting
66 enrolled
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase 1/2 Recruiting
112 enrolled
A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy
Phase 2 Recruiting
72 enrolled
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
Phase NA Recruiting
20 enrolled
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Phase 2 Recruiting
38 enrolled
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
Phase 3 Recruiting
432 enrolled
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
Phase 2 Recruiting
52 enrolled